Alps Advisors Inc Replimune Group, Inc. Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Replimune Group, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 52,301 shares of REPL stock, worth $668,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,301
Previous 47,891 9.21%
Holding current value
$668,929
Previous $431,000 32.95%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$8.09 - $11.23 $35,676 - $49,524
4,410 Added 9.21%
52,301 $573,000
Q2 2024

Aug 13, 2024
BUY
$5.01 - $9.46 $23,030 - $43,487
4,597 Added 10.62%
47,891 $431,000
Q1 2024

May 14, 2024
BUY
$6.87 - $9.31 $24,182 - $32,771
3,520 Added 8.85%
43,294 $353,000
Q4 2023

Feb 14, 2024
SELL
$6.75 - $16.18 $25,488 - $61,095
-3,776 Reduced 8.67%
39,774 $335,000
Q3 2023

Nov 14, 2023
BUY
$15.96 - $22.18 $17,284 - $24,020
1,083 Added 2.55%
43,550 $745,000
Q2 2023

Aug 14, 2023
BUY
$15.65 - $24.1 $80,441 - $123,874
5,140 Added 13.77%
42,467 $986,000
Q1 2023

May 10, 2023
BUY
$17.48 - $29.09 $63,137 - $105,073
3,612 Added 10.71%
37,327 $659,000
Q4 2022

Feb 14, 2023
BUY
$17.09 - $27.91 $115,579 - $188,755
6,763 Added 25.09%
33,715 $917,000
Q3 2022

Nov 14, 2022
SELL
$15.6 - $21.15 $33,727 - $45,726
-2,162 Reduced 7.43%
26,952 $465,000
Q2 2022

Aug 11, 2022
SELL
$13.32 - $19.98 $258,514 - $387,771
-19,408 Reduced 40.0%
29,114 $509,000
Q1 2022

May 16, 2022
SELL
$15.24 - $29.75 $87,584 - $170,973
-5,747 Reduced 10.59%
48,522 $824,000
Q4 2021

Feb 09, 2022
SELL
$25.43 - $34.25 $77,637 - $104,565
-3,053 Reduced 5.33%
54,269 $1.47 Million
Q3 2021

Nov 15, 2021
SELL
$28.98 - $39.54 $117,803 - $160,730
-4,065 Reduced 6.62%
57,322 $1.7 Million
Q2 2021

Aug 11, 2021
SELL
$28.5 - $39.37 $620,188 - $856,730
-21,761 Reduced 26.17%
61,387 $2.36 Million
Q1 2021

May 07, 2021
BUY
$30.22 - $45.57 $55,997 - $84,441
1,853 Added 2.28%
83,148 $2.54 Million
Q4 2020

Feb 03, 2021
BUY
$23.5 - $52.65 $703,026 - $1.58 Million
29,916 Added 58.23%
81,295 $3.1 Million
Q3 2020

Nov 04, 2020
BUY
$18.85 - $27.0 $26,258 - $37,611
1,393 Added 2.79%
51,379 $1.18 Million
Q2 2020

Aug 05, 2020
SELL
$9.76 - $25.95 $145,433 - $386,680
-14,901 Reduced 22.96%
49,986 $1.24 Million
Q1 2020

May 06, 2020
SELL
$8.9 - $19.08 $67,275 - $144,225
-7,559 Reduced 10.43%
64,887 $647,000
Q4 2019

Feb 07, 2020
BUY
$11.61 - $17.21 $841,098 - $1.25 Million
72,446 New
72,446 $1.04 Million

Others Institutions Holding REPL

# of Institutions
149
Shares Held
68M
Call Options Held
52.3K
Put Options Held
80.3K
View Full List

About Replimune Group, Inc.

REPL Quotes by TradingView
  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $631M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email